| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |